139 related articles for article (PubMed ID: 36008654)
1. Plasmid-Based CRISPR-Cas9 Editing in Multiple Candida Species.
Lombardi L; Butler G
Methods Mol Biol; 2022; 2542():13-40. PubMed ID: 36008654
[TBL] [Abstract][Full Text] [Related]
2. Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple
Lombardi L; Oliveira-Pacheco J; Butler G
mSphere; 2019 Mar; 4(2):. PubMed ID: 30867327
[TBL] [Abstract][Full Text] [Related]
3. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.
Lombardi L; Turner SA; Zhao F; Butler G
Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 Editing Induces Loss of Heterozygosity in the Pathogenic Yeast Candida parapsilosis.
Lombardi L; Bergin SA; Ryan A; Zuniga-Soto E; Butler G
mSphere; 2022 Dec; 7(6):e0039322. PubMed ID: 36416551
[TBL] [Abstract][Full Text] [Related]
5. Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
Morio F; Lombardi L; Binder U; Loge C; Robert E; Graessle D; Bodin M; Lass-Flörl C; Butler G; Le Pape P
J Antimicrob Chemother; 2019 Aug; 74(8):2230-2238. PubMed ID: 31106355
[TBL] [Abstract][Full Text] [Related]
6. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
7. Design, execution, and analysis of CRISPR-Cas9-based deletions and genetic interaction networks in the fungal pathogen Candida albicans.
Halder V; Porter CBM; Chavez A; Shapiro RS
Nat Protoc; 2019 Mar; 14(3):955-975. PubMed ID: 30737491
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans.
Evans BA; Pickerill ES; Vyas VK; Bernstein DA
J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507925
[TBL] [Abstract][Full Text] [Related]
9. Forced Recycling of an AMA1-Based Genome-Editing Plasmid Allows for Efficient Multiple Gene Deletion/Integration in the Industrial Filamentous Fungus
Katayama T; Nakamura H; Zhang Y; Pascal A; Fujii W; Maruyama JI
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478227
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Cas9 level for efficient CRISPR-Cas9-mediated chromosomal and plasmid gene deletion in Bacillus thuringiensis.
Soonsanga S; Luxananil P; Promdonkoy B
Biotechnol Lett; 2020 Apr; 42(4):625-632. PubMed ID: 31960185
[TBL] [Abstract][Full Text] [Related]
11. A CRISPR-Cas9 system for multiple genome editing and pathway assembly in Candida tropicalis.
Zhang L; Zhang H; Liu Y; Zhou J; Shen W; Liu L; Li Q; Chen X
Biotechnol Bioeng; 2020 Feb; 117(2):531-542. PubMed ID: 31654413
[TBL] [Abstract][Full Text] [Related]
12. Rapid Hypothesis Testing in Candida albicans Clinical Isolates Using a Cloning-Free, Modular, and Recyclable System for CRISPR-Cas9 Mediated Mutant and Revertant Construction.
Liu J; Vogel AK; Miao J; Carnahan JA; Lowes DJ; Rybak JM; Peters BM
Microbiol Spectr; 2022 Jun; 10(3):e0263021. PubMed ID: 35612314
[TBL] [Abstract][Full Text] [Related]
13. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
[TBL] [Abstract][Full Text] [Related]
14. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
[TBL] [Abstract][Full Text] [Related]
15. Efficient genome editing by CRISPR/Cas9 with a tRNA-sgRNA fusion in the methylotrophic yeast Ogataea polymorpha.
Numamoto M; Maekawa H; Kaneko Y
J Biosci Bioeng; 2017 Nov; 124(5):487-492. PubMed ID: 28666889
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 Genome Editing of Primary Human Vascular Cells In Vitro.
Atri DS; Lee-Kim VS; Vellarikkal SK; Sias-Garcia O; Yanamandala M; Schniztler GR; Gupta RM
Curr Protoc; 2021 Nov; 1(11):e291. PubMed ID: 34748284
[TBL] [Abstract][Full Text] [Related]
17. Comparison of genome engineering using the CRISPR-Cas9 system in C. glabrata wild-type and lig4 strains.
Cen Y; Timmermans B; Souffriau B; Thevelein JM; Van Dijck P
Fungal Genet Biol; 2017 Oct; 107():44-50. PubMed ID: 28822858
[TBL] [Abstract][Full Text] [Related]
18. A CRISPR/Cas9-based strategy to simultaneously inactivate the entire
Zoppo M; Luca MD; Villarreal SN; Poma N; Barrasa MI; Bottai D; Vyas VK; Tavanti A
Future Microbiol; 2019 Nov; 14():1383-1396. PubMed ID: 31659913
[No Abstract] [Full Text] [Related]
19. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
[TBL] [Abstract][Full Text] [Related]
20. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
